FHB
ABMD

First Hawaiian Bank’s Abiomed Inc ABMD Stock Holding History

First Hawaiian Bank’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,861
Closed -$593K – 895
2021
Q1 		$593K Sell
1,861
-95
-5% -$30.4K 0.03% 464
2020
Q4 		$634K Sell
1,956
-95
-5% -$26.3K 0.03% 395
2020
Q3 		$568K Buy
+2,051
New +$591K 0.03% 386
2019
Q3 		– Sell
-1,791
Closed -$467K – 887
2019
Q2 		$467K Sell
1,791
-1,040
-37% -$276K 0.02% 480
2019
Q1 		$809K Buy
2,831
+928
+49% +$308K 0.04% 303
2018
Q4 		$619K Sell
1,903
-200
-10% -$69.5K 0.04% 343
2018
Q3 		$946K Buy
+2,103
New +$829K 0.05% 282

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

First Hawaiian Bank's ABMD Position: Q2 2021 in Review

First Hawaiian Bank sold out of Abiomed Inc (ABMD) in Q2 2021, closing a stake of 1,861 shares — an estimated $593K sold.

First Hawaiian Bank first reported a position in ABMD in Q3 2018 and held it in 7 quarters. The position peaked at $946K in Q3 2018. 474 funds tracked by Wall St. Rank hold ABMD as of Q2 2021.

  • First Hawaiian Bank reported no remaining Abiomed Inc position as of Q2 2021 after selling out during the quarter.
  • First Hawaiian Bank sold 1,861 Abiomed Inc shares in Q2 2021, an estimated $593K.
  • First Hawaiian Bank first reported a position in Abiomed Inc in Q3 2018 and held it in 7 quarters.
  • First Hawaiian Bank's Abiomed Inc position peaked at $946K in Q3 2018.
  • 474 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2021.

Based on First Hawaiian Bank's 13F filing for Q2 2021, filed 8 Jul 2021.